Herborium Group Unveils Additional Products for Acne Harvests Stem Cell Technology

December 04 2019

Fort Lee, December 2019 Herborium Group, Inc. (OTCPink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicines (Botanical Therapeutics) announced today that is expends it anti acne and ski care portfolio by adding unique line of products suitable for acne prone skin of all ages.

The first product of the series – Rejuvel- Infinity® AcnEase® . focused on acne scars, marks and other cosmetic imperfections of the skin. The product line utilizes plant based stem cell technology developed by NASA. Additional products in the series are expected on the market in 2020. This first addition is a part of the expansion plan leading to introduction of the and is the multi product AcnEase Skin Management System.

Rejuvel 3D harnessed healing power of plant cells and antigravity technology used by NASA to speed up collagen production and skin turnover.

No laser or other cream or exfoliator can accelerate the process of skin renewal as those small cells grown in the reduced gravity condition. In addition, with a regular use, those super plump cells will moisturize and rejuvenate the skin while also improving the look of the skin imperfections such as acne scars and marks making the skin look smoother and the imperfections less visible almost instantaneously.

Rejuvel -Infinity is a first step of Herborium Expended Global strategy afforded by AcnEase special status as both beauty and wellness product.

AcnEase meets both requirements and needs of a global beauty market and expectations of the world nutritional and wellness market combining beauty, science and nature as an important tool in service of a healthy and beautiful skin

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, womens health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneasesp.com 

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investorsrelations@herborium.com or DrAgnes@herborium.com